Interestingly, Metzeler et al showed that high expression of lymphoid enhancer binding factor-1 (LEF1) is a favorable AML prognostic factor in non-acute promyelocytic leukemia (APL) AML [4]. The gene discussed is LEF1; the disease is acute promyelocytic leukemia.